Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome

Cancer Genetics and Cytogenetics

Volumn 148, Issue 1, 2004, Pages 29-34

  Iyer, Renuka V ^a   Sait, Sheila N J ^a   Matsui, Sei Ichi ^a   Block, Annemarie W ^a   Barcos, Maurice ^a   Slack, James L ^a   Wetzler, Meir ^a   Baer, Maria R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHROMOSOME 13; CHROMOSOME 15; CHROMOSOME 19; CHROMOSOME 21; CHROMOSOME 5Q; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME STRUCTURE; DIPLOIDY; FEMALE; GENETIC ASSOCIATION; GENETIC GAIN; HUMAN; HUMAN CELL; HYPERDIPLOIDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TETRAPLOIDY;

EID: 0346970934     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00214-0     Document Type: Article

References (46)

1. Mitelman F, Johanson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer, 11/2001 update. Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman . Accessed 2001.
2. Mrózek K., Heinonen K., de la Chapelle A., Bloomfield C.D. Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol. 24:1997;17-31.
3. Slovak M.L., Kopecky K.J., Cassileth P.A., Harrington D.H., Theil K.S., Mohamed A., Paietta E., Willman C.L., Head D.R., Rowe J.M., Forman S.J., Appelbaum F.R. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood. 96:2000;4075-4083.
4. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 92:1998;2322-2333.
5. Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C.J., Wheatley K., Burnett A.K., Goldstone A.H. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the UK Medical Research Council AML11 trial. Blood. 98:2001;1312-1320.
6. Byrd J.C., Mrózek K., Dodge R., Carroll A.J., Edwards C., Pettenati M.J., Patil S.R., Larson R.A., Bloomfield C.D. Pre-treatment cytogenetics predict initial induction success and overall survival in adult patients with de novo myeloid leukemia: results from CALGB 8641. Blood. 98:2001;457a.
7. Faderl S., Kantarjian H.M., Talpaz M., Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood. 91:1998;3995-4019.
8. Wetzler M. Cytogenetics in adult acute lymphocytic leukemia. Hem/Oncol Clin N America. 14:2000;1237-1249.
9. Wetzler M., Dodge R.K., Mrózek K., Carroll A.J., Tantravahi R., Block A.W., Pettenati M.J., Le Beau M.M., Frankel S.R., Stewart C.C., Szatrowski T.P., Schiffer C.A., Larson R.A., Bloomfield C.D. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience. Blood. 93:1999;3983-3993.
10. Groupe Français de Cytogénétique Hématologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique. Blood. 87:1996;3135-3142.
11. Fenaux P., Lai J.L., Morel P., Nelken B., Taboureau O., Deminatti M., Bauters F. Cytogenetics and their prognostic value in childhood and adult lymphoblastic leukemia (ALL) excluding L3. Hematol Oncol. 7:1989;307-317.
12. Pui C.-H., Crist W.M., Look T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 76:1990;1449-1463.
13. Bloomfield C.D., Secker-Walker L.M., Goldman A.I., Van Den Berghe H., de la Chapelle A., Ruutu T., Alimena G., Garson O.M., Golomb H.M., Rowley J.D., Kaneko Y., Whang-Peng J., Prigogina E., Philip P., Sandberg A.A., Lawler S.D., Mitelman F. Six year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 40:1989;171-185.
14. Walters R., Kantarjian H.M., Keating M.J., Estey E.H., Trujillo J., Cork A., McCredie K.B., Freireich E.J. The importance of cytogenetic studies in adult acute lymphocytic leukemia. Am J Med. 89:1990;579-587.
15. Micallef-Eynaud P.D., Eden O.B., Grace E., Ellis P.M. Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 10:1993;25-30.
16. Third International Workshop on Chromosomes in Leukemia. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res. 43:1983;868-873.
17. Harris B., Shuster J.J., Carroll A., Look A.T., Borowitz M.J., Crist W.M., Nitschke R., Pullen J., Steuber C.P., Land V.J. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-cell progenitor acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood. 79:1992;3316-3324.
18. Secker-Walker L.M., Prentice H.G., Durrant J., Richards S., Hall E., Harrison G. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALL XA. Br J Hematol. 96:1997;601-610.
19. Pui C.H., Carroll A.J., Head D., Raimondi S.C., Shuster J.J., Crist W.M., Link M.P., Borowitz M.J., Behm F.G., Land V.J. Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood. 76:1990;590-596.
20. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Daltrin G.A., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Group. Ann Intern Med. 103:1985;620-625.
21. Mertelsmann R., Tzvi Thaler H., To L., Gee T.S., McKenzie S., Schauer P., Friedman A., Arlin Z., Cirrincione C., Clarkson B. Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood. 56:1980;773-781.
22. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol. 78:1991;325-329.
23. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189-199.
24. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
25. 3 60 years old. Blood. 96:2000;322a.
26. Baer M.R., George S.L., Dodge R.K., O'Loughlin K.O., Minderman H., Caligiuri M.A., Anastasi J., Powell B.L., Kolitz J.E., Schiffer C.A., Bloomfield C.D., Larson R.A. Phase III study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B study 9720. Blood. 100:2002;1224-1231.
27. Bernstein S.H., Brunetto V.L., Davey F.R., Wurster-Hill D., Mayer R.J., Stone R.M., Schiffer C.A., Bloomfield C.D. Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B study. J Clin Oncol. 14:1996;2486-2494.
28. Estey E.H., Pierce S., Keating M.J. Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities. Haematologica. 85:2000;246-249.
29. Borgstrom G.H., Vuopio P., de la Chapelle A. Polyploidy of the bone marrow. Scand J Haematol. 17:1976;123-131.
30. Larson R.A., LeBeau M.M., Vardiman J.W., Testa J.R., Golomb H.M., Rowley J.D. The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12 year study (1970-1982). Cancer Genet Cytogenet. 10:1983;219-236.
31. Abe R., Raza A., Preisler H.D., Tebbi C.K., Sandberg A.A. Chromosomes and causation of human cancer and leukemia. LIV. Near-tetraploidy in acute leukemia. Cancer Genet Cytogenet. 14:1985;45-59.
32. Yeh S.P., Wang Y., Su J., Hsueh E., Yu M., Wu H. Near-tetraploid minimally differentiated acute myeloid leukemia with extensive erythrophagocytosis by leukemic blasts. Ann Hematol. 79:2000;36-39.
33. Clarke M.R., Lynch E.F., Contis L.C., Sherer M.E., Shekhter-Levin S. Near-tetraploidy in adult acute myelogenous leukemia. Cancer Genet Cytogenet. 86:1996;107-115.
34. Xue Y., He J., Wang Y., Guo Y., Xie X., He Y., Chai Y., Ruan Z. Secondary near-pentaploidy and/or near-tetraploidy characterized by the duplication of 8;21 translocation in the M2 subtype of acute myeloid leukemia. Int J Hematol. 71:2000;359-365.
35. Lemez P., Michalova K., Zemanova Z., Marinov I., Trpakova A., Moravcova J., Jelinek J. Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors. Leuk Res. 22:1998;581-588.
36. Au W.Y., Ma S.K., Chan A.C., Liang R., Lam C.C., Kwong Y.L. Near tetraploidy in three cases of acute myeloid leukemia associated with mediastinal granulocytic sarcoma. Cancer Genet Cytogenet. 102:1998;50-53.
37. Kwong Y.L., Wong K.F. Hyperdiploid acute myeloid leukemia: relationship between blast size and karyotype demonstrated by fluorescence in situ hybridization. Cancer Genet Cytogenet. 83:1995;1-4.
38. Manley R., Cochrane J., Patton W.N. Polyploidy in myelodysplastic syndrome: a case report. Cancer Genet Cytogenet. 106:1998;170-172.
39. Wong W.Y., Wu S.Q. Pentasomy 8 in pediatric myelodysplastic syndrome. Cancer Genet Cytogenet. 121:2000;220-222.
40. Belli C., Acevedo S., Bengio R., Arrossagaray G., Watman N., Rossi N., Garcia J., Flores G., Goldztein S., Larripa I. Detection of risk groups in myelodysplastic syndromes. A multicenter study. Haematologica. 87:2002;9-16.
41. Morel P., Hebbar M., Lai J.L., Duhamel A., Preudhomme C., Wattel E., Bauters F., Fenaux P. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia. 7:1993;1315-1323.
42. Han K., Lee W., Harris C.P., Kim W., Shim S., Meisner L.F. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH). Leukemia. 8:1994;81-86.
43. Onodera N., McCabe N.R., Rubin C.M. Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood. 80:1992;203-208.
44. Sentein P., Le Coq D. Enhanced polyploidy by glutaraldehyde in cultured HL60 leukemic cells. Leuk Res. 10:1986;575-584.
45. Panzer-Grümayer E.R., Fasching K., Panzer S., Hettinger K., Schmitt K., Stöckler-Ipsiroglu S., Haas O.A. Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis. Blood. 100:2002;347-349.
46. Hagemeijer A., Hahlen K., Abels J. Cytogenetic follow-up of patients with nonlymphocytic leukemia II. Acute nonlymphocytic leukemia . Cancer Genet Cytogenet. 3:1981;109-124.